133 related articles for article (PubMed ID: 9731895)
21. Early FDG-PET imaging after radical radiotherapy for non-small-cell lung cancer: inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation.
Hicks RJ; Mac Manus MP; Matthews JP; Hogg A; Binns D; Rischin D; Ball DL; Peters LJ
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):412-8. PubMed ID: 15380574
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer.
Liao S; Penney BC; Zhang H; Suzuki K; Pu Y
Acad Radiol; 2012 Jan; 19(1):69-77. PubMed ID: 22142679
[TBL] [Abstract][Full Text] [Related]
23. Prognostic evaluations of small size lung cancers by 18F-FDG PET/CT and thin-section CT.
Kishimoto M; Iwano S; Ito S; Kato K; Ito R; Naganawa S
Lung Cancer; 2014 Nov; 86(2):180-4. PubMed ID: 25263854
[TBL] [Abstract][Full Text] [Related]
24. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer.
Sazon DA; Santiago SM; Soo Hoo GW; Khonsary A; Brown C; Mandelkern M; Blahd W; Williams AJ
Am J Respir Crit Care Med; 1996 Jan; 153(1):417-21. PubMed ID: 8542152
[TBL] [Abstract][Full Text] [Related]
25. Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer.
Brown RS; Leung JY; Kison PV; Zasadny KR; Flint A; Wahl RL
J Nucl Med; 1999 Apr; 40(4):556-65. PubMed ID: 10210213
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of posttreatment [18F] fluorodeoxyglucose uptake of primary non-small cell lung carcinoma treated with radiation therapy with or without chemotherapy: a brief review.
Kased N; Erasmus JJ; Komaki R; Cox JD
J Thorac Oncol; 2008 May; 3(5):534-8. PubMed ID: 18449010
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of 18 F-fluorodeoxyglucose - positron emission tomography after treatment in patients with limited stage small cell lung cancer.
Onitilo AA; Engel JM; Demos JM; Mukesh B
Clin Med Res; 2008 Sep; 6(2):72-7. PubMed ID: 18801952
[TBL] [Abstract][Full Text] [Related]
28. The clinical impact of the sum of the maximum standardized uptake value on the pretreatment with F-FDG-PET/CT in small-cell lung cancer.
Go SI; Song HN; Kang JH; Kang MH; Kim MJ; Jung J; Chung SI; Choi BH; Hwang IG; Kim SH; Ling H; Lee GW
Oncology; 2014; 86(1):1-9. PubMed ID: 24335538
[TBL] [Abstract][Full Text] [Related]
29. Metabolic activity on [18f]-fluorodeoxyglucose-positron emission tomography/computed tomography and glucose transporter-1 expression might predict clinical outcomes in patients with limited disease small-cell lung cancer who receive concurrent chemoradiation.
Lee J; Kim JO; Jung CK; Kim YS; Yoo IeR; Choi WH; Jeon EK; Hong SH; Chun SH; Kim SJ; Kim YK; Kang JH
Clin Lung Cancer; 2014 Mar; 15(2):e13-21. PubMed ID: 24368212
[TBL] [Abstract][Full Text] [Related]
30. [Staging with 18F-FDG-PET/CT influences stage-specific survival in advanced non-small cell lung cancer (NSCLC)].
Tönnies S; Bauer TT; Misch D; Boch C; Blum T; Bittner RC; Förster GJ; Kollmeier J
Pneumologie; 2012 Apr; 66(4):212-7. PubMed ID: 22477481
[TBL] [Abstract][Full Text] [Related]
31. Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer.
Marom EM; Aloia TA; Moore MB; Hara M; Herndon JE; Harpole DH; Goodman PC; Patz EF
Lung Cancer; 2001; 33(2-3):99-107. PubMed ID: 11551404
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of fluorodeoxyglucose uptake in non-small cell lung cancer: time for standardization and validation.
Dooms C; Vansteenkiste J
J Thorac Oncol; 2010 May; 5(5):583-4. PubMed ID: 20421763
[No Abstract] [Full Text] [Related]
33. [(18)F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer.
Dhital K; Saunders CA; Seed PT; O'Doherty MJ; Dussek J
Eur J Cardiothorac Surg; 2000 Oct; 18(4):425-8. PubMed ID: 11024379
[TBL] [Abstract][Full Text] [Related]
34. Fluorodeoxyglucose positron emission tomography and the prognosis of pancreatic carcinoma.
Zimny M; Fass J; Bares R; Cremerius U; Sabri O; Buechin P; Schumpelick V; Buell U
Scand J Gastroenterol; 2000 Aug; 35(8):883-8. PubMed ID: 10994629
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary hypertrophic osteoarthropathy in a patient with nonsmall cell lung cancer: Diagnosis with FDG PET/CT.
Strobel K; Schaefer NG; Husarik DB; Hany TF; Steinert H
Clin Nucl Med; 2006 Oct; 31(10):624-6. PubMed ID: 16985370
[No Abstract] [Full Text] [Related]
36. Positron emission tomography and improved survival in patients with lung cancer: the Will Rogers phenomenon revisited.
Chee KG; Nguyen DV; Brown M; Gandara DR; Wun T; Lara PN
Arch Intern Med; 2008 Jul; 168(14):1541-9. PubMed ID: 18663166
[TBL] [Abstract][Full Text] [Related]
37. FDG PET measurement of the proliferative potential of non-small cell lung cancer.
Higashi K; Ueda Y; Yagishita M; Arisaka Y; Sakurai A; Oguchi M; Seki H; Nambu Y; Tonami H; Yamamoto I
J Nucl Med; 2000 Jan; 41(1):85-92. PubMed ID: 10647609
[TBL] [Abstract][Full Text] [Related]
38. Author's correction. "Incidental findings on integrated PET/CT that do not accumulate 18F-FDG".
Bruzzi JF
AJR Am J Roentgenol; 2007 Feb; 188(2):300. PubMed ID: 17249144
[No Abstract] [Full Text] [Related]
39. Re: Prognostic value of FDG uptake in early stage non-small cell lung cancer.
Chong CF
Eur J Cardiothorac Surg; 2008 Oct; 34(4):932; author reply 932-3. PubMed ID: 18703347
[No Abstract] [Full Text] [Related]
40. Use of anthropometric factors in 18F-FDG PET bone marrow SUVs.
Thie JA
J Nucl Med; 2006 Nov; 47(11):1901-2; author reply 1902. PubMed ID: 17079825
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
